Black Hawk Acquisition Corporation Class A Ordinary Shares (BKHA)
Stock · NASDAQ · Health Care
$6.01as of 10/16/2026
Price chart
Active signals
BKHA Signal Track Record
How signals performed across all stocks →What BKHA's price did in the 20 trading sessions after each past signal, compared with any 20-session window over the same period.
| Signal | Times | Median 20-session return | Higher after 20 sessions | Last signal |
|---|---|---|---|---|
| Bollinger Band Breakout | 14 | +0.1% | 64% | October 7, 2026 |
| Any 20-session window (baseline) | +0.5% | 77% |
Computed by MarketWall from daily closing prices since February 28, 2025. Returns are close-to-close and don't include dividends. Past results describe what happened before; they are not a forecast and not investment advice.
About BKHA
Black Hawk Acquisition Corporation is a blank check company focuses on effecting a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses or entities. The company was incorporated in 2023 and is based in Danville, California.
- Sector
- Health Care
- Industry
- Biotechnology: Biological Products (No Diagnostic Substances)
- Website
- www.bhspac.com/
Fundamentals
- 1-day range
- $11.95$23
- Market cap
- $—
- P/E (trailing)
- 136.64
- P/E (forward)
- —
- EPS (trailing)
- $0.08
- Dividend yield
- —
- Beta
- 0.12
- Avg. volume
- 6.6K
Black Hawk Acquisition Corporation Class A Ordinary Shares Competitors
Chosen by industry and closest market cap.
- BKHABlack Hawk Acquisition Corporation Class A Ordinary Shares$6.01▼ 12.26%Market cap $—P/E 136.64$9.5$23
- SLXNWSilexion Therapeutics Corp Warrant$0.0054▼ 10.00%Market cap $21.3KP/E —$0.0051$0.1508
- TVGNWTevogen Inc. Warrant$0.0689▼ 1.57%Market cap $320.8KP/E —$0.0253$0.08
- BTTCBlack Titan Corporation Ordinary Shares$0.368▼ 6.84%Market cap $1.02MP/E —$0.3415$10.05
- SCNIScinai Immunotherapeutics Ltd. American Depositary Shares$0.752▼ 16.63%Market cap $1.30MP/E 0.16$0.75$15.65
- SLXNSilexion Therapeutics Corp Ordinary Shares$0.153▼ 19.05%Market cap $1.90MP/E —$0.2362$42.6
- CLDICalidi Biotherapeutics Inc. Common Stock$0.837▼ 3.79%Market cap $4.38MP/E —$0.82$27.84
| Symbol | Market cap | P/E ratio | Price | 1D | 52-week range |
|---|---|---|---|---|---|
| BKHA Black Hawk Acquisition Corporation Class A Ordinary Shares | $— | 136.64 | $6.01 | ▼ 12.26% | $9.5$23 |
| SLXNW Silexion Therapeutics Corp Warrant | $21.3K | — | $0.0054 | ▼ 10.00% | $0.0051$0.1508 |
| TVGNW Tevogen Inc. Warrant | $320.8K | — | $0.0689 | ▼ 1.57% | $0.0253$0.08 |
| BTTC Black Titan Corporation Ordinary Shares | $1.02M | — | $0.368 | ▼ 6.84% | $0.3415$10.05 |
| SCNI Scinai Immunotherapeutics Ltd. American Depositary Shares | $1.30M | 0.16 | $0.752 | ▼ 16.63% | $0.75$15.65 |
| SLXN Silexion Therapeutics Corp Ordinary Shares | $1.90M | — | $0.153 | ▼ 19.05% | $0.2362$42.6 |
| CLDI Calidi Biotherapeutics Inc. Common Stock | $4.38M | — | $0.837 | ▼ 3.79% | $0.82$27.84 |
P/E shows — for peers not currently carrying a live signal of their own.
See the full, filterable feed with live charts on the MarketWall dashboard.